Cutaneous T-Cell Lymphoma - Competitive Landscape, Market Insights, Epidemiology and Market Forecast-2025

Published: November 2017
No. of Pages: 221
Price: Single User: US $ 6950  US $ 5560 Corporate User: US $ 20850  US $ 12510

This report is available at 20% Discount for Single User License and 40% Discount for Corporate Users License till 31 December 2017. To avail discount please contact at +1-888-391-5441 /

Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight’s “Cutaneous T-Cell Lymphoma – Competitive Landscape, Market Insights, Epidemiology and Market Forecast-2025”report provides an overview of the disease, the comprehensive insights on the competitive landscape and market of Cutaneous T-Cell Lymphoma.

The Report covers detailed historical and forecasted epidemiology of Cutaneous T-Cell Lymphoma(CTCL) in the 7MM (till 2025), segmented on the basis of sub-types (Mycosis fungoides, Sezary syndrome and others i.e., Primary cutaneous peripheral T-cell lymphoma, ATLL, primary cutaneous CD30+ T-cell lymphoproliferative disorders, subcutaneous panniculitis-like T-cell lymphoma (SPTCL) and unspecified), gender (predominant in males) as well as stages of the disease (Early Stage and Late Stage).

The Report also includes market trends of the Cutaneous T-Cell Lymphoma for the seven major markets i.e., United States, EU5 (France, Germany, Italy, Spain, and UK) and Japan. The Report covers the therapeutics market revenue, treatment practice/algorithm and forecasted market size of Cutaneous T-Cell Lymphoma from 2017 to 2025 segmented by seven major markets. In addition, the report also covers market drivers, market barriers and unmet medical need.

The competitive landscape of the report covers both pipeline and marketed portfolio of the indication. Cutaneous T-Cell Lymphoma pipeline provides information on the therapeutic drugs in development and comparative analysis at various stages covering clinical and pre-clinical & discovery stages, therapeutics assessment by Monotherapy/Combination products and Molecule Type drug analysis. It also provides in-depth analysis on the Phase III profile covering clinical trial studies, recent developments and SWOT Analysis.

The United States accounts for the highest incident population of CTCL in comparison to EU5 countries and Japan. According to DelveInsight, it is estimated that the incident cases of CTCL in the United States shall increase at a CAGR of 0.35% from 2013 to 2025.

The treatment of CTCL depends on the disease stage. Early stage therapies are topical, including corticosteroids, retinoids, imiquimod (Aldara), ultraviolet A irradiation (PUVA), and total skin electron beam therapy. Systemic therapies are introduced in the advanced stages where the disease is widespread and/or resistant to topical treatment. These include interferon alpha injections, stem cell transplant, alemtuzumab (MabCampath) and other chemotherapy regimens. The FDA approved drugs are Istodax (romidepsin), Valchlor (mechlorethamine), Uvadex (methoxsalen), Targretin (bexarotene) and Zolinza (vorinostat). The drugs have been considered in our report as per NCCN (United States) guidelines.

Amongst all the 7MM, United States accounts for highest market share for CTCL due to high incidence as well as due to high annual cost of therapy. According to DelveInsight, the Cutaneous T-Cell Lymphoma market size in 7MM is estimated to increase at a compound annual growth rate (CAGR) of 1.6% for the forecasted period i.e., 2013-2025.

Scope of the report

- Overview of the Global pipeline scenario for Cutaneous T-Cell Lymphoma , products and associated companies information

- Pipeline analysis across different phases, emerging trends and comparative analysis of pipeline products with detailed clinical profiles, mechanism of action, route of administration and molecule type, along with product development activities.

- The Report provides detailed historical and forecasted epidemiological data of Cutaneous T-Cell Lymphoma in the 7MM i.e., United States, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan from 2013-2025.

- Organize sales and marketing efforts by identifying the best opportunities for Cutaneous T-Cell Lymphoma in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.

- To understand the future market competition in the global Cutaneous T-Cell Lymphoma market and Insightful review of the key market drivers and barriers.

- The report will help in developing business strategies by understanding the trends shaping and driving the global Cutaneous T-Cell Lymphoma market.

- Key topics covered include strategic competitor assessment, barriers and drivers in the market along with SWOT analysis

- The Report also covers the detailed historical and forecasted Cutaneous T-Cell Lymphoma market covering United States, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan from 2013-2025.


Published By: Delve Insight
Product Code: Delve Insight11

Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Related Reports:


  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Consumer Goods market as per your needs. Get the best of Consumer Goods research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: